Max Robotics — Global Service Robot Directory + US Certification

About

Garret Choby is a leading head and neck surgeon whose research has fundamentally reshaped the management of oropharyngeal cancer, particularly through the lens of transoral robotic surgery (TORS). His work centers on optimizing surgical outcomes, minimizing complications, and personalizing treatment to preserve quality of life. Choby’s landmark study analyzing post-TORS hemorrhage established critical preventative protocols, a contribution cited over 100 times for its direct impact on patient safety. He is perhaps best known for demonstrating that TORS alone—without adjuvant radiation or chemotherapy—can achieve excellent oncologic control while maintaining superior quality of life in carefully selected patients, a finding that has empowered de-escalation strategies. His comparative research showing comparable oncologic outcomes between TORS and definitive chemoradiation has helped solidify surgery’s role as a first-line option. With a portfolio of highly cited papers, including a seminal 2015 study on TORS alone that has garnered 76 citations, Choby has proven that up-front robotic surgery can precisely tailor adjuvant therapy, reducing unnecessary toxicity. His work continues to guide evidence-based, patient-centered care in the rapidly evolving field of oropharyngeal cancer treatment.